Detalles de la búsqueda
1.
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
Blood
; 139(11): 1684-1693, 2022 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34614146
2.
End of induction positron emission tomography complete response (PET-CR) as a surrogate for progression-free survival in previously untreated follicular lymphoma.
Br J Haematol
; 198(2): 333-337, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35491747
3.
Late isolated central nervous system relapse in childhood B-cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: A report from the Children's Oncology Group study AALL02P2.
Pediatr Blood Cancer
; 68(12): e29256, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34302704
4.
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.
N Engl J Med
; 377(14): 1331-1344, 2017 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28976863
5.
The architecture of neoplastic follicles in follicular lymphoma; analysis of the relationship between the tumor and follicular helper T cells.
Haematologica
; 105(6): 1593-1603, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31537685
6.
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy.
Am J Hematol
; 95(12): 1503-1510, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32815559
7.
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
Haematologica
; 104(6): 1202-1208, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30573503
8.
Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first-line immunochemotherapy.
Br J Clin Pharmacol
; 85(7): 1495-1506, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30866056
9.
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial.
Lancet Oncol
; 19(11): 1530-1542, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30309758
10.
Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma.
Blood
; 137(19): 2704-2707, 2021 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512481
11.
A retrospective analysis of post-transplant lymphoproliferative disorder following liver transplantation.
Eur J Haematol
; 100(1): 98-103, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29094407
12.
Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group study.
Pediatr Blood Cancer
; 65(5): e26928, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29286562
13.
Non-Hodgkin lymphoma of the cauda equina: a rare entity.
Br J Neurosurg
; 31(6): 734-735, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27568648
14.
Obinutuzumab Treatment of Follicular Lymphoma.
N Engl J Med
; 377(26): 2605-2606, 2017 12 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29281572
15.
Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000).
Blood
; 122(7): 1137-43, 2013 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23843495
16.
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
Haematologica
; 105(5): 1465, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32358081
17.
Long-term outcomes of alemtuzumab-based reduced-intensity conditioned hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myelogenous leukemia secondary to myelodysplastic syndrome.
Biol Blood Marrow Transplant
; 20(1): 111-7, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24216184
18.
Late toxicity following craniospinal radiation for early-stage medulloblastoma.
Acta Oncol
; 53(4): 471-80, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24564687
19.
Local control in non-metastatic medulloblastoma.
Acta Oncol
; 53(9): 1151-7, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24991891
20.
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study.
J Clin Oncol
; 42(5): 550-561, 2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096461